<?xml version="1.0" encoding="UTF-8"?>
<p>
 <italic>NS4B inhibitors</italic>: Very few studies on ZIKV NS4B protein inhibition are performed so far, mainly because of poor ADME properties of the identified inhibitors. Search for NS4B inhibitors faces many challenges, such as poor drug-like properties of the inhibitors and difficulties in finding pan-flaviviral inhibitors avoiding risk of developing resistant viruses [
 <xref rid="B117-pharmaceuticals-12-00157" ref-type="bibr">117</xref>,
 <xref rid="B118-pharmaceuticals-12-00157" ref-type="bibr">118</xref>,
 <xref rid="B119-pharmaceuticals-12-00157" ref-type="bibr">119</xref>].
</p>
